Status:
UNKNOWN
Pre-emptive Trans-cutaneous Versus Trans-oral Ultrasound Guided Peritonsillar Infiltration With Bupivacaine During Tonsillectomy
Lead Sponsor:
Assiut University
Conditions:
Postoperative Pain Management
Eligibility:
All Genders
3-15 years
Phase:
NA
Brief Summary
Ultrasound as a technique is safe, readily available, quick and portable allowing more accuracy of different regional blocks and local infiltration. It allows imaging of the mouth, oropharynx, infrahy...
Eligibility Criteria
Inclusion
- ASA (American Society of Anesthesiologists) physical status I-II with no airway complications or systemic diseases or known psychological diseases. Reason for their surgery was recurrent or chronic tonsillitis.
Exclusion
- Infection at the site of injection, peritonsillar abscess or cellulites.
Key Trial Info
Start Date :
December 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2018
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03361813
Start Date
December 10 2017
End Date
February 1 2018
Last Update
December 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Azhar University Hospital
Cairo, Egypt